Unknown

Dataset Information

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies.


ABSTRACT:

Background

Disease-modifying therapies are thought to reduce the conversion rate to secondary progressive multiple sclerosis.

Objective

To explore the rate, chronology, and contributing factors of conversion to the progressive phase in treated relapsing-remitting multiple sclerosis patients.

Methods

Our study included 204 patients treated for relapsing-remitting multiple sclerosis between 1995 and 2002, prospectively followed to date. Kaplan-Meier analysis was applied to estimate the time until secondary progressive multiple sclerosis conversion, and multivariate survival analysis with a Cox regression model was used to analyse prognostic factors.

Results

Relapsing-remitting multiple sclerosis patients were continuously treated for 13 years (SD 4.5); 36.3% conv

SUBMITTER: Coret F 

PROVIDER: S-EPMC6077906 | biostudies-literature | 2018 Apr-Jun

REPOSITORIES: biostudies-literature